Summary
We have previously demonstrated that confluent fetal fibroblasts migrate into three-dimensional collagen gels to a significantly greater extent than their normal adult counterparts. Recent studies have revealed that this behavioral difference results from the secretion by fetal fibroblasts of a soluble migration-stimulating factor (MSF) which acts on these cells in an autocrine fashion. Adult fibroblasts do not produce MSF but remain responsive to it. Skin fibroblasts from cancer patients resemble fetal fibroblasts (rather than normal adult cells) with respect to their migratory behavior on collagen gels and continued production of MSF. This communication is concerned with elucidating the biochemical basis of MSF activity. Data are presented indicating that a) hyaluronic acid is required for the elevated migratory activity displayed by confluent fetal and breast cancer patient skin fibroblast; b) adult fibroblasts exhibit a bell-shaped dose-response to MSF, with maximal stimulation of migration observed at a concentration of 10 ng/ml; c) the migratory activity of adult fibroblasts pre-incubated with MSF remains high in the absence of additional factor: and d) MSF affects both the quantity and size class distribution of hyaluronic acid synthesized by adult fibroblasts. We have previously speculated that the persistent fetal-like fibroblasts of breast cancer patients play a direct role in disease pathogenesis by perturbing normal epithelial-mesenchymal interactions. The observations reported here suggest that MSF-induced alterations in hyaluronic acid synthesis may contribute to the molecular basis of such perturbations.
Similar content being viewed by others
References
Antecol, M. H.; Darveau, A.; Sonenberg, N., et al. Altered biochemical properties of actin in normal skin fibroblasts from individuals predisposed to dominantly inherited cancers. Cancer Res. 46:1867–1873; 1986.
Azzarone, B.; Mareel, M.; Billard, C., et al. Abnormal properties of skin fibroblasts from patients with breast cancer. Int. J. Cancer 33:759–764; 1984.
Bertolami, C. N.; Donoff, R. B. Hyaluronidase activity during open wound healing in rabbits. J. Surg. Res. 25:256–259; 1978.
Bissell, M.; Hall, H. G.; Parry, G. How does the extracellular matrix direct gene expression? J. Theor. Biol. 99:31–68; 1982.
Bronson, R. E.; Argenta, J. G.; Bertolami, C. N. Interleukin-1 induced changes in extracellular glycosaminoglycan composition of cutaneous scar-derived fibroblasts in culture. Collagen Relat. Res. 8:199–208; 1988.
Cappelletti, R.; Del Rosso, M.; Chiarugi, V. Rapid multisample separation of the five most widespread animal glycosaminoglycans. Anal. Biochem. 93:37–40; 1979.
Castellani, P.; Siri, A.; Rosellini, C., et al. Transformed cells release different fibronectin variants than do normal cells. J. Cell Biol. 103:1671–1678; 1986.
Cantrella, M.; McCarthy, T. L.; Canalis, E. Transforming growth factor-beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures of fetal rat bone. J. Biol. Chem. 262:2869–2874; 1987.
Chen, T. R. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33238 stain. Exp. Cell Res. 104:255–262; 1977.
Clemmons, D. R. Age-dependent production of a competence factor by human fibroblasts. J. Cell. Physiol. 114:61–67; 1983.
Durning, P.; Schor, S. L.; Sellwood, R. A. S. Fibroblasts from patients with breast cancer shop abnormal migratory behaviour in vitro. Lancet I:890–892; 1984.
Elstad, C. A.; Hosick, H. L. Contribution of the extracellular matrix to growth properties of cells from a preneoplastic outgrowth: possible role of hyaluronic acid. Exp. Cell Biol. 55:313–321; 1987.
Feinberg, R. N.; Beebe, D. C. Hyaluronate in vasculogenesis. Science 220:1177–1179; 1983.
Forrester, J. V.; Balazs, E. A. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 40:435–446; 1980.
Goldberg, R. L.; Toole, B. P. Hyaluronate inhibition of cell proliferation. Arthritis Rheum. 30:769–777; 1987.
Green, S. J.; Underhill, C. B. Hyaluronate appears to be covalently linked to the cell surface. J. Cell. Physiol. 134:376–386; 1988.
Grey, A. M.; Schor, A. M.; Rushton, G., et al. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc. Natl. Acad. Sci. USA 86:2438–2442; 1989.
Haggie, J.; Howell, A.; Sellwood, R. A., et al. Fibroblasts from relatives of patients with hereditary breast cancer show fetal-like behaviourin vitro. Lancet I:1455–1457; 1987.
Ham, R. G. Dermal fibroblasts. In: Methods in cell physiology, vol. 21. Harris, C.; Trump, B. F.; Stoner, G., eds. New York: Academic Press; 1980:255–276.
Hill, D. J.; Strain, A. J.; Elstow, S. F., et al. Bifunctional action of transforming growth factor-beta on DNA synthesis in early passage human fetal fibroblasts. J. Cell. Physiol. 128:322–328; 1986.
Hopwood, J. J.; Dorfman, A. Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40. J. Biol. 252:4777–4785; 1977.
Iozzo, R. V. Neoplastic modulation of the extracellular matrix: colon carcinoma cells release polypeptides that alter proteoglycan metabolism in colon fibroblasts. J. Biol. Chem. 260:7464–7475; 1985.
Knudson, W.; Biswas, C.; Toole, B. P. Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc. Natl. Acad. Sci. USA 81:6767–6771; 1984.
Kujawa, M. J.; Carrino, D. A.; Caplan, A. I. Substrate-bonded hyaluronic acid exhibits a size-dependent stimulation of chondrogenic differentiation of stage 24 limb mesenchymal cells in culture. Dev. Biol. 114:519–528; 1986.
Kujawa, M.; Pechak, D. G.; Fiszman, M. Y., et al. Hyaluronic acid bonded to cell culture surfaces inhibits the program of myogenesis. Dev. Biol. 113:10–16; 1986.
Lacy, B. E.; Underhill, C. B. The hyaluronate receptor is associated with actin filaments. J. Cell Biol. 105:1395–1404; 1987.
Lawrence, D. A.; Pircher, C. K. M.; Jullien, P. Normal embryo fibroblasts release transforming growth factor in latent form. J. Cell. Physiol. 121:184–188; 1984.
Manley, G.; Warren, C. Serum hyaluronic acid in patients with disseminated neoplasm. J. Clin. Pathol. 40:626–630; 1987.
Markwald, R. R.; Fitzharris, T. P.; Bank, H., et al. Structural analysis on the matrical organization of glycosaminoglycans in developing endocardial cushions. Dev. Biol. 62:292–316; 1978.
Matsura, H.; Hakamori, S. I. The oncofetal domain of fibronectin defined by a monoclonal antibody FDC-6: Its presence in fetal and tumor tissues and its absence in those from normal tissue and plasma. Proc. Natl. Acad. Sci. USA 83:6517–6521; 1985.
Matuoka, K.; Mitsui, Y.; Murota, S. I. Growth coupled changes in glycosaminoglycans (heparan sulfate and hyaluronic acid) in normal and transformed human fibroblasts. Cell Biol. Int. Rep. 9:577–586; 1985.
McGuire, P. G.; Castellot, J. J.; Orkin, R. W. Size-dependent hyaluronate degradation by cultured cells. J. Cell. Physiol. 133:267–276; 1987.
Mescher, A. L.; Munaim, S. I. Changes in the extracellular matrix and glycosaminoglycin synthesis during the initiation of regeneration in adult newt forelimbs. Anat. Rec. 214:424–431; 1986.
Mian, N. Analysis of cell growth phase related variations in hyaluronate synthase activity of isolated plasma membrane fractions of cultured human skin fibroblasts. Biochem. J. 237:333–342; 1986.
Nakano, S.; Ts’o, P. O. Cellular differentiation and neoplasia: characterization of subpopulations of cells that have neoplasia-related growth properties in Syrian hamster embryo cell cultures. Proc. Natl. Acad. Sci. USA 78:4995–4999; 1981.
Nigam, V. N.; Brailovsky, C. A.; Bonaventura, J. Glycosaminoglycans and proteoglycans in neoplastic tissues and their role in tumour growth and metastasis. In: Varma, R. S.; Varma, R., eds. Glycosaminoglycans and proteoglycans in Physiological and Pathological Process of Body Systems. Basel: Karger Press; 1982:354–371.
Orkin, R. W.; Toole, B. P. Hyaluronidase activity and hyaluronate content of the developing chick embryo heart. Dev. Biol. 66:308–320; 1978.
Parker, R. E. Introductory statistics for biology, 2nd ed. London: Edward Arnold; 1979.
Pfeffer, L.; Lipkin, M.; Stutman, O., et al. Growth abnormalities of cultured skin fibroblasts derived from individuals with hereditary adenomatosis of the colon and rectum. J. Cell. Physiol. 89:29–38; 1976.
Pintar, J. E. Distribution and synthesis of glycosaminoglycans during quail neural crest morphogenesis. Dev. Biol. 67:444–464; 1978.
Pratt, R. M.; Larsen, M. A.; Johnston, M.C. Migration of cranial neural crest cells in a cell-free hyaluronate-rich matrix. Dev. Biol. 44:298–305; 1975.
Schachtschabel, D. O.; Sluke, G. Increase of cellular hyaluronic acid synthesis following continuous exposure of cultured human fibroblasts (WI-38) to hydrocortisone. Z. Gerontol. 19:173–178; 1986.
Schor, S. L. Cell proliferation and migration within three-dimensional collagen gels. J. Cell Sci. 41:159–175; 1980.
Schor, S. L.; Court, J. Different mechanisms involved in the attachment of cells to native and denatured collagen. J. Cell Sci. 38:267–281; 1979.
Schor, S. L.; Schor, A. M. Foetal-to-adult transitions in fibroblast phenotype: their possible relevance to the pathogenesis of cancer. J. Cell Sci. Suppl. 8:165–180; 1987.
Schor, S. L.; Schor, A. M. Clonal heterogeneity in fibroblast phenotype: implications for the control of epithelial-mesenchymal interactions. BioEssays 7:200–204; 1987.
Schor, S. L.; Schor, A. M.; Rushton, G., et al. Adult, foetal and transformed fibroblasts display different migratory phenotypes on collagen gels: evidence for an isoformic transition during foetal development. J. Cell Sci. 73:221–234; 1985.
Schor, S. L.; Schor, A. M.; Durning, P., et al. Skin fibroblasts obtained from cancer patients display foetal-like behaviour on collagen gels. J. Cell Sci. 73:235–244; 1985.
Schor, S. L.; Haggie, J. A.; Durning, P., et al. Occurrence of a fetal fibroblast phenotype in familial breast cancer. Int. J. Cancer 37:831–836; 1986.
Schor, S. L.; Schor, A. M.; Howell, A., et al. Hypothesis: Persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease. Exp. Cell Biol. 55:11–17; 1987.
Schor, S. L.; Schor, A. M.; Grey, A. M., et al. Foetal and cancer patient fibroblasts produce an autocrine migration stimulating factor not made by normal adult cells. J. Cell Sci. 90:391–399; 1988.
Shimada, E.; Matasumura, G. Degradative processes of hyaluronic acid by Streptomyces hyaluronidase. J. Biochem. 88:1015–1023; 1978.
Smith, G. N.; Toole, B. P.; Gross, J. Hyaluronidase activity and glycosaminoglycan synthesis in the amputated newt limb. Dev. Biol. 42:221–232; 1975.
Toole, B. P.; Biswas, C.; Gross, J. Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc. Natl. Acad. Sci. USA 76:6299–6303; 1979.
Toole, B. P.; Tresltad, R. L. Hyaluronate production and removal during corneal development in the chick. Dev. Biol. 26:28–35; 1971.
Turley, E. A.; Torrance, J. Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Exp. Cell Res.161:17–28; 1984.
Turley, E. A.; Bowman, P.; Kytryk, M. A. Effects of hyaluronate and hyaluronate-binding proteins on cell motile and contact behavior. J. Cell Sci. 78:133–145; 1985.
Turley, E. A.; Hollenberg, M. D.; Pratt, R. M. Effects of epidermal growth factor/urogastrone on glycosaminoglycan synthesis and accumulation in vitro in the developing mouse palate. Differentiation 28:279–285; 1985.
Welch, D. W.; Roberts, R. M. Complex saccharide metabolism in cystic fibrosis. Pediatr. Res. 9:698–702; 1975.
Weigel, P. H.; Fuller, G. M.; LeBoeuf, R. D. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J. Theor. Biol. 119:219–234; 1986.
West, D. C.; Hampson, I. N.; Arnold, F., et al. Angiogenesis induced by degradation products of hyaluronic acid. Science 228:1324–1326; 1985.
Yamagata, T.; Saito, H.; Habuchi, O., et al. Purification and properties of bacterial chondroitinases and chondrosculfatases. J. Biol. Chem. 243:1523–1535; 1968.
Yoneda, M.; Yamagata, M.; Suzuki, S., et al. Hyaluronic acid modulates proliferation of mouse dermal fibroblasts in culture. J. Cell Sci. 90:265–273; 1988.
Author information
Authors and Affiliations
Additional information
This work was funded by grants from the Cancer Research Campaign (CRC) and Medical Research Council (MRC), London, England.
Rights and permissions
About this article
Cite this article
Schor, S.L., Schor, A.M., Grey, A.M. et al. Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: Effect on hyaluronic acid synthesis. In Vitro Cell Dev Biol 25, 737–746 (1989). https://doi.org/10.1007/BF02623727
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02623727